1. Home
  2. CAPR vs AXL Comparison

CAPR vs AXL Comparison

Compare CAPR & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPR
  • AXL
  • Stock Information
  • Founded
  • CAPR 2005
  • AXL 1994
  • Country
  • CAPR United States
  • AXL United States
  • Employees
  • CAPR N/A
  • AXL N/A
  • Industry
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • AXL Auto Parts:O.E.M.
  • Sector
  • CAPR Health Care
  • AXL Consumer Discretionary
  • Exchange
  • CAPR Nasdaq
  • AXL Nasdaq
  • Market Cap
  • CAPR 578.4M
  • AXL 576.1M
  • IPO Year
  • CAPR N/A
  • AXL 1999
  • Fundamental
  • Price
  • CAPR $15.00
  • AXL $5.61
  • Analyst Decision
  • CAPR Strong Buy
  • AXL Hold
  • Analyst Count
  • CAPR 7
  • AXL 6
  • Target Price
  • CAPR $39.29
  • AXL $6.75
  • AVG Volume (30 Days)
  • CAPR 902.1K
  • AXL 2.9M
  • Earning Date
  • CAPR 03-03-2025
  • AXL 02-14-2025
  • Dividend Yield
  • CAPR N/A
  • AXL N/A
  • EPS Growth
  • CAPR N/A
  • AXL N/A
  • EPS
  • CAPR N/A
  • AXL 0.29
  • Revenue
  • CAPR $23,228,045.00
  • AXL $6,124,900,000.00
  • Revenue This Year
  • CAPR N/A
  • AXL N/A
  • Revenue Next Year
  • CAPR $74.85
  • AXL N/A
  • P/E Ratio
  • CAPR N/A
  • AXL $19.47
  • Revenue Growth
  • CAPR 65.33
  • AXL 0.75
  • 52 Week Low
  • CAPR $3.52
  • AXL $4.70
  • 52 Week High
  • CAPR $23.40
  • AXL $7.98
  • Technical
  • Relative Strength Index (RSI)
  • CAPR 52.56
  • AXL 53.34
  • Support Level
  • CAPR $14.28
  • AXL $4.70
  • Resistance Level
  • CAPR $16.47
  • AXL $5.93
  • Average True Range (ATR)
  • CAPR 1.00
  • AXL 0.24
  • MACD
  • CAPR 0.07
  • AXL 0.11
  • Stochastic Oscillator
  • CAPR 55.05
  • AXL 72.40

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.

About AXL American Axle & Manufacturing Holdings Inc.

American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.

Share on Social Networks: